Onconic Therapeutics Receives MFDS Approval for JAQBO, a New Treatment for Gastroesophageal Reflux Disease (GERD)

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Onconic-MFDS-Approval

More Like This

PR Newswire associated0

Onconic Therapeutics Announces Positive Phase 3 Results for JAQBO at Digestive Diseases Week 2024

Implantica submits U.S. FDA Premarket Approval (PMA) application for RefluxStop® (first module)

Implantica announces new health-economics data publication showing RefluxStop™'s superior cost-effectiveness for the Swiss healthcare system

Implantica's RefluxStop™ garners strong interest at SAGES

Implantica announces a newly published real-world study from Germany reinforcing the excellent RefluxStop™ results

Implantica announces RefluxStop™ pivotal 4-year study results published in the prestigious journal Surgical Endoscopy

Implantica's RefluxStop™ health economic research, showing superior cost-effectiveness, has received top-recognition at ISPOR, the world's leading European Health-Economics Conference

Implantica announces another landmark real-world RefluxStop™ study demonstrating excellent outcomes published in a prestigious top-tier journal